TORO (T-20 vs. Optimized Regimen Only
TORO-1
North and South America
491 patients
TORO-2
Europe and Australia
504 patients
Heavily triple-class experienced
Trial Structure
Patient Randomization
TORO-1
TORO-2
Fuzeon + OB
OB
Previous slide
Next slide
Back to first slide
View graphic version